| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
prostate cancer associated transcript 1 | 0.575 | 0.615 |
|
disease | 0.500 | None | 1.000 | 11 | 21 | 2005 | 2019 | |||||||||
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
disease | 0.100 | None | 1.000 | 9 | 11 | 2007 | 2014 | |||||||||
|
cancer susceptibility 19 | 0.769 | 0.423 |
|
disease | 0.100 | None | 1.000 | 8 | 12 | 2007 | 2013 | |||||||||
|
prostate cancer associated non-coding RNA 1 | 0.722 | 0.385 |
|
disease | 0.170 | None | 1.000 | 6 | 4 | 2008 | 2019 | |||||||||
|
POU class 5 homeobox 1B | 0.670 | 0.346 | 2.9E-04 |
|
disease | 0.140 | None | 1.000 | 5 | 6 | 2007 | 2017 | ||||||||
|
colon cancer associated transcript 2 | 0.621 | 0.615 |
|
disease | 0.110 | None | 1.000 | 5 | 2 | 2007 | 2016 | |||||||||
|
microseminoprotein beta | 0.498 | 0.846 | 1.6E-02 |
|
disease | 0.700 | None | 0.984 | 4 | 1 | 1993 | 2020 | ||||||||
|
HNF1 homeobox B | 0.473 | 0.808 | 1.00 |
|
disease | 0.500 | None | 0.864 | 4 | 4 | 2007 | 2020 | ||||||||
|
kallikrein related peptidase 3 | 0.443 | 0.885 | 4.4E-06 |
|
disease | 0.500 | None | 0.958 | 2 | 2 | 1989 | 2020 | ||||||||
|
lemur tyrosine kinase 2 | 0.729 | 0.462 | 1.00 |
|
disease | 0.440 | None | 1.000 | 2 | 2 | 2008 | 2016 | ||||||||
|
protocadherin alpha 7 | 1.000 | 0.077 | 5.0E-09 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | ||||||||
|
capping protein inhibiting regulator of actin dynamics | 0.792 | 0.192 | 5.3E-05 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2007 | 2007 | ||||||||
|
catenin beta like 1 | 0.621 | 0.731 | 9.7E-03 |
|
disease | 0.110 | None | 1.000 | 1 | 3 | 2008 | 2019 | ||||||||
|
protocadherin alpha 1 | 0.805 | 0.192 | 6.0E-08 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2014 | 2014 | ||||||||
|
protocadherin alpha 2 | 0.931 | 0.115 | 1.0E-23 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2014 | 2014 | ||||||||
|
protocadherin alpha 3 | 0.861 | 0.192 | 8.4E-16 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2014 | 2014 | ||||||||
|
kallikrein related peptidase 15 | 0.705 | 0.385 | 1.5E-02 |
|
disease | 0.190 | None | 1.000 | 1 | 1 | 2001 | 2018 | ||||||||
|
protocadherin gamma subfamily A, 2 | 1.000 | 0.077 | 5.5E-16 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | ||||||||
|
protocadherin alpha 4 | 0.839 | 0.115 | 2.0E-23 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2014 | 2014 | ||||||||
|
protocadherin alpha 5 | 0.931 | 0.115 | 5.8E-08 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | ||||||||
|
protocadherin gamma subfamily A, 1 | 1.000 | 0.077 | 1.6E-07 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | ||||||||
|
protocadherin alpha 6 | 0.931 | 0.115 | 3.6E-11 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | ||||||||
|
lipid droplet associated hydrolase | 0.839 | 0.231 | 3.6E-04 |
|
disease | 0.450 | None | 1.000 | 1 | 1 | 2010 | 2018 | ||||||||
|
eukaryotic elongation factor, selenocysteine-tRNA specific | 0.751 | 0.385 | 2.7E-08 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2009 | 2009 | ||||||||
|
cadherin EGF LAG seven-pass G-type receptor 1 | 0.700 | 0.500 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 |